MTHFD2 and hepatocellular carcinoma: Increased MTHFD2 levels are also associated with the migration, invasion, and poor clinical prognosis of breast cancer [239], NSCLC [240], RCC [241], hepatocellular carcinoma (HCC) [242], squamous cell carcinoma (SCC) [243], and ovarian cancer [244].